Author:
Coffin Carla S.,Terrault Norah A.
Reference121 articles.
1. AASLD/IDSA/IAS–USA. HCV guidance: recommendations for testing, managing, and treating hepatitis C. http://www.hcvguidelines.org/ (accessed September 11, 2017)
2. Abbas Z, Khan MA, Salih M, et al. Interferon alpha for chronic hepatitis D. Cochrane Database Syst Rev 2011;12:CD006002.
3. Abbas Z, Memon MS, Mithani H, et al. Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience. Antivir Ther. 2014;19:463–8.
4. Abbas Z, Memon MS, Umer MA, et al. Co-treatment with pegylated interferon alfa-2a and entecavir for hepatitis D: a randomized trial. World J Hepatol. 2016;8:625–31.
5. Alberti A, Pontisso P, Chemello L, et al. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease. J Hepatol. 1995;22:38–41.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献